Basking Biosciences Advances Innovative Stroke Treatment with New CEO and Funding for Clinical Trials Basking Biosciences has initiated its Phase 2 stroke trial, appointed Dr. Julia C. Owens as CEO, and secured $27.5 million in funding.

Basking Biosciences Advances Innovative Stroke Treatment with New CEO and Funding for Clinical Trials #USA #Research_Triangle #Basking_Biosciences #BB-031 #Julia_Owens